As an initial step toward this goal, the present study directly compares gp100 expression across a panel of cutaneous and uveal melanoma cell lines and interrogates the range of gp100 expression in cutaneous melanoma specimens and nevi. This evidence concerns the gene PMEL and cutaneous melanoma.